Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids

Johns Hopkins Med J. 1982 Oct;151(4):164-72.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adrenoleukodystrophy / diet therapy
  • Adrenoleukodystrophy / drug therapy
  • Adrenoleukodystrophy / therapy*
  • Adult
  • Brain / diagnostic imaging
  • Carnitine / therapeutic use*
  • Clofibrate / therapeutic use*
  • Diffuse Cerebral Sclerosis of Schilder / therapy*
  • Fatty Acids / blood*
  • Humans
  • Male
  • Tomography, X-Ray Computed

Substances

  • Fatty Acids
  • Clofibrate
  • Carnitine